 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
 | |  | |  | |  | |  | |  | |  |
| Press Release: Smiths Detection and NCS Pharmaceuticals Expand Support Offerings for Smiths' Clients Globally COMPETITIVE TECHNOLOGIES FORMS ALLIANCE WITH NCS PHARMACEUTICALS NCS Pharmaceuticals Analytical/Bio-analytical Services Capabilities include: Method and Protocol Development/Validation/Transfer as per current FDA/USP/ICH compliances. Analytical and Bio-analytical stability indicating release method development for finished product for small organic molecule based active pharmaceutical ingredients, validation and transfer as per cGMP / ICH guidelines. Pre-clinical IND studies for PK/TOX/ADME studies of investigative small organic molecule/small Peptide based drugs. Impurity Profiles for active drug substance and drug products. Container aqueous and volatiles Leachables/Extractables organic and inorganic chemical species. Analytical R&D support for Proteomics/Biomarker discovery aims to identify protein markers for early detection of diseases. Support for pre-clinical drug discovery and development (screening of commercial or client-supplied libraries of small molecules using cell-based assays). Support ELISA-based diagnostic assays. Support for Biomarker discovery of different diseases. NCS Pharmaceuticals instrumentation, equipment, and analytical methodologies: Chromatography (TLC, GC, HPLC, GC/MS/MS, LC/MS/MS, IC, GPC, DSC, Headspace Analyzer, ICP-MS, MALDI-ESI-QTOF). Spectroscopy (FTIR, UV/visible, Atomic Absorption, Inductively Coupled Plasma-Atomic Emission (ICP-AE, spectrofluorimetry). Titrimetry, including Karl Fischer reagent and Oven/Coulometry for water content Disintegration/Dissolution (including extended release). Fluorescence 2-dimensional differential in-gel electrophoresis (2D- DIGE). Protein/antibody Microarray for biomarker discovery. ELISA-based assays using Luminex technology. Screening of library of small molecules for drug discovery and development using Biomek 2000 or Biomek FX automated workstation (BECKMAN COULTER). NCS Pharmaceuticals is also a full-fledged organization for Commissioning, Engineering Design, Qualification / Validation and Regulatory Affairs of the cGMP Biopharmaceutical, Medical Devices, Pharmaceutical and Food industries. NCS Pharmaceuticals employees have been greatly involved with the commissioning and validation of equipment, systems and entire facilities since the inception of validation by the pharmaceutical industry. We utilize our cGMP compliance and validation methodology which is developed by NCS Pharmaceuticals to optimize the execution of the commissioning and validation phases of a project. This methodology allows us to generate a cost effective validation program minimizes overall project execution time. Our employees are highly qualified in the industry who are continually trained in the latest developments in the field. NCS Pharmaceuticals provides validation services independently or in conjunction with commissioning operations in order to optimize project cost and time. NCS Pharmaceuticals will deliver the services required to meet your specific needs. NCS Pharmaceuticals offers the following activities:
|